Corporate Health is a key driver in the transformation of healthcare in Asia. HealthTech innovation offers employers and employees with a wealth of resources to enable this transformation. Galen Growth Asia showcases the corporate health solutions landscape.

1. ©2018 by Galen Growth Asia - All rights reserved.
Galen Growth Asia
The Asia HealthTech
Connector & Builder
HealthTech: The Corporate
Health Landscape

2. ©2018 by Galen Growth Asia - All rights reserved.
CALL TO ACTION
Corporate Health will be a key driver of healthcare transformation in Asia
• Corporate Health is being transformed by the convergence of HealthTech
and InsurTech innovation
• HealthTech innovation in Asia is in rude health: 2nd largest ecosystem in
the world!
• HealthTech offers solutions to combat the rising health burden and
healthcare costs for employers
• Employers now have the opportunity to build a meaningful portfolio of
solutions to address their employees’ health needs
• HealthTech innovation is enabling an employee’s desire for greater
engagement in and ownership of their health

3. ©2018 by Galen Growth Asia - All rights reserved.
ABOUT US
Our Mission
Founded in late 2015 by five HealthTech innovators, Galen
Growth Asia (GGA), is at the epicentre of HealthTech
innovation, aka digital health, currently a $70+B startup
ecosystem.
GGA has built a portfolio of solutions which enables it to
be the catalyst of direct collaboration between enterprise,
startups and investors to prototype, evaluate and
implement HealthTech solutions to solve healthcare
system pain points and create significant financial and
social value in the region.
We
Engage Innovators
GGA has established the most comprehensive and relevant network of HealthTech
Startups and innovators across the region which includes entrepreneurs, investors,
enterprise innovation teams, and many other key stakeholder groups
Scan Solutions
GGA has built the only dedicated HealthTech ventures database and analytics
platform allowing it and its clients to scan, screen and develop valuable insights.
Through its rich network and this unique database, GGA is the leading authority in
the Asia Pacific HealthTech ecosystem through its comprehensive analysis of the
landscape.
Accelerate Strategies
By leveraging its thought leadership, research, data and unique ecosystem network,
GGA is in the enviable position of assisting enterprise, investors and startup ventures
to accelerate the design and execution their HealthTech growth strategies

4. ©2018 by Galen Growth Asia - All rights reserved.
OUR CAPABILITIES
HealthTech
Tribe Events
HealthTech Alpha
Asia HealthTech
Council
HealthTech
Advisory
Asia’s only dedicated annual HealthTech Summit: The Summit for the most innovative
minds in Asia HealthTech: Investor Day and Enterprise Day
Quarterly HealthTech Tribe events – connecting the ecosystem movers and shakers – by
invitation only
The Moneyball of Asia HealthTech!
Asia HealthTech’s most comprehensive ecosystem analytics platform, used by
investors, enterprise and startups, giving access to unique insights on the
thousands of digital health startups in Asia Pacific
The HealthTech Council propels the ambitions of innovation leaders through their peer-to-peer
collaborative and reflective practices to build and enable the future of healthcare in Asia.
By nurturing meaningful conversations along with sharing best practices and experiences, members
work together to create breakthroughs that translate into greater business innovation successes
Specialist Digital Health advisory to Enterprise, Investors & Startups
Design: The Why&What - Accelerate the design of a client’s digital health strategy
incl. alignment of internal stakeholders
Execution: The How&Who – Construct & kick-off the strategy execution plan incl.
identification of suitable startups for potential partnership

5. ©2018 by Galen Growth Asia - All rights reserved.
• Funding in H1 2018 exceeds $3.3B, more
than double compared to H1 2017
• H1 2018 funding in the USA is $3.5B!
• Deal volume is 40% lower compared YoY
so deal size is growing
• Pre-IPO and IPO made up 63% of the
total funding deployed
• Without the outlier, the $1.1B IPO by
Ping An Hao Daifu (Good Doctor), total
funding grew by 53% compared to H1
2017
ASIA HEALTHTECH FUNDING HISTORY
2016 - 2018$242
$1,286
$1,286
$1,286
$826
$1,372
$2,077
$2,761
$902
$3,292
33
60
91
128
73
158
206
245
49
107
$0
$500
$1,000
$1,500
$2,000
$2,500
$3,000
$3,500
-70
-20
30
80
130
180
230
2016 Investments ($M) 2017 Investments ($M) 2018 Investments ($M)
2016 Deals 2017 Deals 2018 Deals

6. ©2018 by Galen Growth Asia - All rights reserved.
HEALTHTECH TAXONOMY

7. ©2018 by Galen Growth Asia - All rights reserved.
• 7 of the 15 HealthTech
categories have the
potential to either directly
and indirectly influence
Corporate Health
outcomes
• A number of HealthTech
ventures offer an
integrated Corporate
Health value proposition
• Employers now have the
opportunity to build a
portfolio of solutions to
engage employees in their
health
BY CATEGORY

8. ©2018 by Galen Growth Asia - All rights reserved.

9. ©2018 by Galen Growth Asia - All rights reserved.
https://www.linkedin.com/company/galen-growth-asia/
https://twitter.com/galengrowthasia
https://www.galengrowth.asia
info@galengrowth.asia
Thank you!
For further information